Medication-assisted treatment, or MAT, combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders. It is one of the most effective, evidence-based approaches available for opioid and alcohol addiction. Yet myths and stigma still keep many people from accessing it. This article explains how MAT works and the science behind it. It is educational and is not a substitute for professional medical advice.
According to SAMHSA, medication-assisted treatment uses medications, in combination with counseling and behavioral therapies, to provide a "whole-patient" approach to treating substance use disorders. The goal is not to replace one drug with another, but to normalize brain chemistry, relieve cravings and withdrawal, and free a person to engage fully in counseling and rebuild their life.
MAT is backed by strong scientific evidence. The National Institute on Drug Abuse (NIDA) states that medications for opioid use disorder are safe, effective, and reduce the risk of overdose death. By easing withdrawal and cravings, these medications help people stay in treatment longer, which is strongly linked to better outcomes.
Three main medications are FDA-approved to treat opioid addiction, each working in a different way:
Buprenorphine is a partial opioid agonist, meaning it activates opioid receptors but to a much lesser degree than full opioids like heroin or fentanyl. The SAMHSA explains that it relieves withdrawal symptoms and cravings without producing the same intense high, and has a "ceiling effect" that lowers the risk of misuse. Suboxone combines buprenorphine with naloxone to further discourage misuse.
Methadone is a long-acting full opioid agonist that, taken at the proper dose, prevents withdrawal and reduces cravings without producing euphoria. It is dispensed through certified opioid treatment programs and has decades of evidence supporting its effectiveness.
Naltrexone is an opioid antagonist; it blocks opioid receptors so that opioids cannot produce a high. Vivitrol is an extended-release, once-monthly injectable form. Because it is not an opioid and is not addictive, naltrexone is a good option for people who have already completed detox.
MAT is not only for opioids. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) describes three FDA-approved medications for alcohol use disorder: naltrexone, acamprosate, and disulfiram. These can reduce cravings and support people in cutting back or stopping drinking when combined with counseling.
Medication is only half of MAT. Counseling and behavioral therapy help people understand the roots of their addiction, develop coping skills, repair relationships, and prevent relapse. Our medication-assisted treatment programs pair medications with individual and group therapy. For people whose addiction co-occurs with depression, anxiety, or trauma, integrated dual-diagnosis treatment addresses both conditions together.
One of the most important benefits of MAT for opioid use disorder is its life-saving potential. When a person stops using opioids, their tolerance drops quickly. If they relapse and take the amount they once used, the risk of a fatal overdose is extremely high, a danger made worse by the prevalence of fentanyl. Medications like buprenorphine and methadone stabilize the system, reduce cravings, and keep people connected to care, which is why NIDA links them to lower overdose mortality. In this sense, MAT does not just support recovery; it can keep people alive long enough to recover.
Beginning MAT starts with a thorough medical evaluation. Your provider reviews your substance use history, physical and mental health, and goals, then recommends the medication and dose most likely to help. For buprenorphine, treatment usually begins once mild withdrawal has started; for naltrexone, you generally need to be fully detoxed first. Throughout treatment, your team monitors your progress, adjusts the plan as needed, and integrates counseling so the medication and therapy reinforce each other.
Some people wrongly believe that taking medication for addiction is "not real recovery." In reality, MAT is a medical treatment for a medical condition, much like insulin for diabetes. NIDA and SAMHSA both recognize it as a frontline, evidence-based treatment. Choosing MAT is a courageous, informed step toward health, and research consistently shows it improves the odds of long-term success.
The best medication and approach depend on your history, health, and goals, and that decision should be made with a qualified medical provider. If you or a loved one is in crisis, call or text the 988 Suicide & Crisis Lifeline. For free, confidential help and referrals, call the SAMHSA National Helpline at 1-800-662-4357.
California Treatment Centers is in-network with most major insurers and has multiple California locations. We offer free, confidential insurance verification so you can explore your MAT options with no obligation. Call 213-321-6518 to get started.
We're in-network with most major insurers. We confirm your benefits and report back, usually within a few hours. HIPAA & 42 CFR Part 2 protected.
Call 213-321-6518